Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Doria

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Nature Medicine|January 8, 2013
Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistanceChong Wee Liew, Jeremie Boucher, Jit Kong Cheong, et al.
European Journal of Human Genetics : EJHG|September 11, 2008
Genome-wide linkage screen for stature and body mass index in 3.032 families: evidence for sex- and population-specific genetic effectsSampo Sammalisto, Tero Hiekkalinna, Karen Schwander, et al.
Atherosclerosis|September 13, 2011
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cellsSabrina Prudente, Eleonora Morini, Jay Larmon, et al.
American Journal of Human Genetics|June 16, 2015
Loss-of-Function Mutations in APPL1 in Familial Diabetes MellitusSabrina Prudente, Prapaporn Jungtrakoon, Antonella Marucci, et al.
Diabetes Care|August 17, 2016
Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical TrialHetal S Shah, He Gao, Mario Luca Morieri, et al.
Diabetes Care|September 29, 2018
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical TrialMario Luca Morieri, He Gao, Marie Pigeyre, et al.
Acta Diabetologica|February 3, 2022
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetesSerena Pezzilli, Tommaso Mazza, Maria Giovanna Scarale, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 DiabetesDaniel M Rotroff, Sonja S Pijut, Skylar W Marvel, et al.
JAMA|August 29, 2013
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetesLu Qi, Qibin Qi, Sabrina Prudente, et al.
Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Nature Medicine|January 8, 2013
Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistanceChong Wee Liew, Jeremie Boucher, Jit Kong Cheong, et al.
European Journal of Human Genetics : EJHG|September 11, 2008
Genome-wide linkage screen for stature and body mass index in 3.032 families: evidence for sex- and population-specific genetic effectsSampo Sammalisto, Tero Hiekkalinna, Karen Schwander, et al.
Atherosclerosis|September 13, 2011
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cellsSabrina Prudente, Eleonora Morini, Jay Larmon, et al.
American Journal of Human Genetics|June 16, 2015
Loss-of-Function Mutations in APPL1 in Familial Diabetes MellitusSabrina Prudente, Prapaporn Jungtrakoon, Antonella Marucci, et al.
Diabetes Care|August 17, 2016
Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical TrialHetal S Shah, He Gao, Mario Luca Morieri, et al.
Diabetes Care|September 29, 2018
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical TrialMario Luca Morieri, He Gao, Marie Pigeyre, et al.
Acta Diabetologica|February 3, 2022
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetesSerena Pezzilli, Tommaso Mazza, Maria Giovanna Scarale, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 DiabetesDaniel M Rotroff, Sonja S Pijut, Skylar W Marvel, et al.
JAMA|August 29, 2013
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetesLu Qi, Qibin Qi, Sabrina Prudente, et al.
Nature Communications|August 7, 2025
Urinary Complement proteome strongly linked to diabetic kidney disease progressionZaipul I Md Dom, Salina Moon, Eiichiro Satake, et al.
Pageof 14